E-Mail
PHILADELPHIA Approximately 6.5 million people are under correctional supervision in the United States on any given day. Justice-involved individuals (people currently or recently in prison or jail, on probation or parole, or arrested) experience higher rates of substance use disorders than the general population. In fact, among people with opioid use disorder (OUD), more than half have reported contact with the criminal justice system.
Numerous clinical studies have shown that medications for OUD specifically, methadone or buprenorphine lead to superior outcomes for retention in treatment, reduced illicit opioid use, and decreased opioid-related overdose rates and serious acute care compared with treatments that rely on psychosocial interventions alone. However, due to a number of barriers, including access to health insurance, access to medications for OUD for those on parole, formerly incarcerated, or recently arrested remain significantly lower than the general po
A team led by scientists at the Perelman School of Medicine at the University of Pennsylvania has illuminated the functions of mysterious structures in cells called nuclear speckles, showing that they can work in partnership with a key protein to enhance the activities of specific sets of genes.
UAB Health System CEO Will Ferniany to retire at year’s end
Updated 11:32 AM;
Facebook Share
UAB Health System CEO Will Ferniany has announced he will retire at year’s end.
Selwyn Vickers, senior vice president and dean of the UAB School of Medicine, will succeed Ferniany as CEO of system and CEO of the new UAB/Ascension St. Vincent’s Alliance, while continuing in his role of dean of the medical school.
Ferniany has headed the system since 2008, watching it grow from five hospitals to 11, with revenues expanding from $2.3 billion in 2008 to more than $5.8 billion today.
UAB President Ray Watts said Ferniany “has enjoyed a long and distinguished career that led to transformational change for UAB Medicine and health care in Birmingham and across Alabama.”
WIC Nutrition Program increased enrollment shifting from paper vouchers to electronic eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Single mRNA vaccine dose may be enough for those previously exposed to SARS-CoV-2
New research supports the notion that those who have recovered from coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, may only need one dose of an mRNA vaccine to boost immunity. The findings showed no increase in circulating antibodies targeting the virus’s spike protein or antigen-specific memory B-cells after recovered individuals received their second dose.
The boost in immunity from the first mRNA vaccine could help with population immunity by allocating additional doses to high-risk groups, unexposed individuals, and countries in need of vaccines. To date, over 117.5 million cases of COVID-19 have been confirmed worldwide, resulting in over 2.6 million deaths.